SCHEMBL5834757

SCHEMBL5834757

CCN(CC)c1ccc(NC(=O)[C@]2(NC(=O)OCC(C)C)CCc3cc(/C=C/C(N)=O)ccc3C2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 4/20 0.71
KCNH2 Q12809 1/20 0.43
MAPT P10636 6/20 0.36
KDM4E B2RXH2 4/20 0.36
ALDH1A1 P00352 4/20 0.36
LMNA P02545 3/20 0.36
HPGD P15428 2/20 0.36
FGFR1 P11362 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.32
KMT2A Q03164 3/20 0.32
GAA P10253 3/20 0.32
APAF1 O14727 1/20 0.32
HTT P42858 1/20 0.32
BACE1 P56817 1/20 0.32
MEN1 O00255 2/20 0.32
CNR2 P34972 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.31
GFER P55789 2/20 0.31
POLB P06746 1/20 0.31
CRHBP P24387 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5835325 1.00 GHSR (0.71) GHSRKCNH2MAPTKDM4EALDH1A1
SCHEMBL5835380 0.85 GHSR (0.79) GHSRKCNH2MAPTALDH1A1LMNA
SCHEMBL5835476 0.85 GHSR (0.79) GHSRKCNH2MAPTALDH1A1LMNA
SCHEMBL5835656 0.84 GHSR (0.78) GHSRKCNH2MAPTALDH1A1LMNA
SCHEMBL5835243 0.84 GHSR (0.78) GHSRKCNH2MAPTALDH1A1LMNA
SCHEMBL5835139 0.83 GHSR (1.00) GHSRKCNH2MAPTALDH1A1LMNA
SCHEMBL5835330 0.78 GHSR (0.41) GHSRKCNH2MAPTKDM4EALDH1A1
SCHEMBL5834764 0.78 GHSR (0.41) GHSRKCNH2MAPTKDM4EALDH1A1
SCHEMBL5835333 0.78 GHSR (0.41) GHSRKCNH2MAPTKDM4EALDH1A1
SCHEMBL5834760 0.78 GHSR (0.41) GHSRKCNH2MAPTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7115767-B2 Tetraline derivatives as ghrelin receptor modulators ABBOTT LABORATORIES (US) 2006-10-03 US claimed
US-20050014794-A1 Tetraline derivatives as ghrelin receptor modulators ABBVIE INC. 2005-01-20 US claimed
US-7115767-B2 Tetraline derivatives as ghrelin receptor modulators ABBOTT LABORATORIES (US) 2006-10-03 US disclosed
US-20050014794-A1 Tetraline derivatives as ghrelin receptor modulators ABBVIE INC. 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014794-A1 Tetraline derivatives as ghrelin receptor modulators GPR119, GHSR, GIPR GHSR 2/4885KCNH2 3931/4885MAPT 3095/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.